Summary of presentation
Inflammation versus sepsis: focus on biomarkers
Despite an increasing variety of markers of systemic inflammation are offered, they do not allow reliable differentiation of its aetiology. The reasons for this phenomenon are explained. Markers are clinical useful only if consequences for therapy and diagnosis are significant. This has been confirmed for antibiotic therapy, risk evaulation and assessment of therapeutic and diagnostic interventions.